Loading...
Impact of blood-based biomarkers on survival outcomes with pembrolizumab in pre-treated advanced non-small cell lung cancer (NSCLC) patients (pts)
Tay, Rebecca Chiramel, Jaseela Montague, E Wilson, F Summers, Yvonne J
Tay, Rebecca
Chiramel, Jaseela
Montague, E
Wilson, F
Summers, Yvonne J
Citations
Altmetric:
Abstract
Description
Date
2018
Publisher
Collections
Files
Loading...
From UNPAYWALL
Adobe PDF, 101.68 KB
Keywords
Type
Meetings and Proceedings
Citation
Tay RY, Chiramel J, Montague E, Wilson F, Summers Y, Blackhall FH, et al. 1462P Impact of blood-based biomarkers on survival outcomes with pembrolizumab in pre-treated advanced non-small cell lung cancer (NSCLC) patients (pts). Ann Oncol. 2018;29(suppl_8):529.